Zavicefta 2g/0.5g powder for concentrate for solution for infusion

  • Name:

    Zavicefta 2g/0.5g powder for concentrate for solution for infusion

  • Company:
    info
  • Active Ingredients:

    Ceftazidime Pentahydrate, Avibactam sodium

  • Legal Category:

    Product subject to medical prescription which may not be renewed (A)

Patient Information Leaflet Patient Information Leaflet last updated on medicines.ie: 19/02/20

files-icon(Click to Download)
Summary of Product Characteristics last updated on medicines.ie: 12/4/2019
This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions. See section 4.8 for how to report adverse reactions.

Click on this link to Download PDF directly

Pfizer Healthcare Ireland

Pfizer Healthcare Ireland

Company Products

Medicine NameActive Ingredients
Medicine Name Depo-Medrone 40mg/ml 2ml vial Active Ingredients Methylprednisolone Acetate
Medicine Name Depo-Medrone 40mg/ml 3ml vial Active Ingredients Methylprednisolone Acetate
Medicine Name Depo-Medrone 40mg/ml with Lidocaine 10mg/ml Suspension for Injection, 2ml Vial Active Ingredients Lidocaine Hydrochloride, Methylprednisolone Acetate
Medicine Name Depo-Provera 150mg/ml Active Ingredients Medroxyprogesterone Acetate
Medicine Name Detrusitol 1 mg filmcoated tablets Active Ingredients Tolterodine tartrate
Medicine Name Detrusitol 2 mg film coated tablets Active Ingredients Tolterodine tartrate
Medicine Name Detrusitol SR 2 mg, prolonged-release, hard; Active Ingredients Tolterodine tartrate
Medicine Name Detrusitol SR 4 mg, prolonged-release, hard Active Ingredients Tolterodine tartrate
Medicine Name Dexamethasone Phosphate 4 mg/ml Solution for Injection Active Ingredients Dexamethasone Sodium Phosphate
Medicine Name Diflucan 10 mg/ml powder for oral suspension Active Ingredients Fluconazole
Medicine Name Diflucan 200 mg hard Capsules Active Ingredients Fluconazole
Medicine Name Diflucan 2mg/ml Solution for Infusion Active Ingredients Fluconazole
Medicine Name Diflucan 40 mg/ml powder for oral suspension Active Ingredients Fluconazole
Medicine Name Diflucan 50 mg hard Capsules Active Ingredients Fluconazole
Medicine Name DIFLUCAN CAPSULES 150MG Active Ingredients Fluconazole
Medicine Name Dopamine Hydrochloride 40 mg/ml Sterile Concentrate Active Ingredients Dopamine Hydrochloride
Medicine Name Dostinex 500 microgram Tablets Active Ingredients Cabergoline
Medicine Name Dynastat 40 mg Powder for Solution for Injection Active Ingredients Parecoxib sodium
Medicine Name Ecalta 100 mg powder for concentrate for solution for infusion Active Ingredients Anidulafungin
Medicine Name Edronax 4mg Tablets Active Ingredients Reboxetine
Medicine Name Efexor XL 150 mg hard prolonged release capsules Active Ingredients venlafaxine hydrochloride
Medicine Name Efexor XL 37.5 mg hard prolonged release capsules Active Ingredients venlafaxine hydrochloride
Medicine Name Efexor XL 75 mg hard prolonged release capsules Active Ingredients venlafaxine hydrochloride
Medicine Name Enbrel 10 mg powder and solvent for solution for injection for paediatric use Active Ingredients Etanercept
Medicine Name ENBREL 25 mg powder and solvent for solution for injection. Active Ingredients Etanercept
51 - 75 of 227 items.Total: 10 pages

When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 19 February 2020 PIL

Reasons for updating

  • Change to section 6 - manufacturer
  • Change to section 6 - date of revision

Updated on 6 December 2019 PIL

Reasons for updating

  • Change to section 6 - date of revision

Updated on 15 April 2019 PIL

Reasons for updating

  • Change to section 6 - date of revision

Updated on 12 April 2019 SmPC

Reasons for updating

  • Change to section 10 - Date of revision of the text

Legal category: Product subject to medical prescription which may not be renewed (A)

Updated on 31 October 2018 PIL

Reasons for updating

  • Change to section 6 - date of revision

Updated on 31 October 2018 SmPC

Reasons for updating

  • Change to section 10 - Date of revision of the text

Legal category: Product subject to medical prescription which may not be renewed (A)

Free text change information supplied by the pharmaceutical company

The SPC has been updated as follows:

Section 10: DATE OF REVISION OF THE TEXT has been updated – (10/2018)

Updated on 25 July 2018 PIL

Reasons for updating

  • Change to section 2 - excipient warnings
  • Improved presentation of PIL

Updated on 25 July 2018 SmPC

Reasons for updating

  • Change to section 4.2 - Posology and method of administration
  • Change to section 4.4 - Special warnings and precautions for use

Legal category: Product subject to medical prescription which may not be renewed (A)

Free text change information supplied by the pharmaceutical company

Sections 4.2 (Posology and method of administration) and 4.8 (Undesirable effects) updated following completion of the paediatric study C3591004.

Section 4.4 sodium statement updated to align with the Annex to the EU Commission guideline on ‘Excipients in the labelling and package leaflet of medicinal products for human use’.

Updated on 6 February 2018 SmPC

Reasons for updating

  • New SmPC for new product

Legal category: Product subject to medical prescription which may not be renewed (A)

Updated on 6 February 2018 SmPC

Reasons for updating

  • Change to section 7 - Marketing authorisation holder

Legal category: Product subject to medical prescription which may not be renewed (A)

Free text change information supplied by the pharmaceutical company

The SPC has been updated as follows:
Section 7 - MA Holder address "Operations Services Group" corrected to "Operations Support Group".

Updated on 5 February 2018 PIL

Reasons for updating

  • New PIL for new product

Updated on 5 February 2018 PIL

Reasons for updating

  • Change to section 6 - marketing authorisation holder
  • Change to section 6 - date of revision

Updated on 8 January 2018 PIL

Reasons for updating

  • New PIL for new product

Updated on 8 January 2018 SmPC

Reasons for updating

  • New SPC for new product

Legal category: Product subject to medical prescription which may not be renewed (A)

Free text change information supplied by the pharmaceutical company

None provided